2003 | Ahmedin Jemal, PhD, DVM; Taylor Murray; Alicia Samuels, MPH; Asma Ghafoor, MPH; Elizabeth Ward, PhD; Michael J. Thun, MD, MS
The American Cancer Society estimates that in 2003, 1,334,100 new cancer cases and 556,500 cancer deaths will occur in the United States. Age-adjusted cancer death rates declined in both males and females in the 1990s, with a more significant decline in males. Incidence rates continued to increase in females while stabilizing in males. African-American males showed the largest decline in mortality, but African Americans still have the highest burden of cancer, with later-stage diagnoses and poorer survival compared to Whites. Despite the decline in cancer death rates, the total number of recorded cancer deaths continues to increase slightly due to population aging and growth. The report also provides detailed statistics on cancer incidence, mortality, and survival rates for various racial and ethnic groups, highlighting disparities in cancer outcomes. Additionally, it discusses trends in cancer incidence and mortality, survival rates, and the impact of screening on prostate cancer.The American Cancer Society estimates that in 2003, 1,334,100 new cancer cases and 556,500 cancer deaths will occur in the United States. Age-adjusted cancer death rates declined in both males and females in the 1990s, with a more significant decline in males. Incidence rates continued to increase in females while stabilizing in males. African-American males showed the largest decline in mortality, but African Americans still have the highest burden of cancer, with later-stage diagnoses and poorer survival compared to Whites. Despite the decline in cancer death rates, the total number of recorded cancer deaths continues to increase slightly due to population aging and growth. The report also provides detailed statistics on cancer incidence, mortality, and survival rates for various racial and ethnic groups, highlighting disparities in cancer outcomes. Additionally, it discusses trends in cancer incidence and mortality, survival rates, and the impact of screening on prostate cancer.